Associate Professor of Medicine, Louisiana State U Shrevport
Hematology
Dr. Reinhold Munker, MD
|
|
Give Review
Doctor Reinhold Munker, MD works in the field of Hematology. He has 2 awards "America's Top Doctors" and "America's Top Doctors for Cancer". Doctor Reinhold Munker, MD is also a published doctor. He has 102 publication published. The most recent publication is: Vitamin D analogs, leukemia and WAF1. Reinhold Munker is registered with Medicare and accepts Medicare payments.
Publications
- Allogeneic hematopoietic cell transplantation for patients with mixed phenotype Acute leukemia.
- Treatment-related MDS/AML in a patient after treatment for Large-cell neuroendocrine lung cancer.
- Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma.
- Alternative donors extend transplantation for patients with Lymphoma who lack an HLA matched donor.
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- Multiple Myeloma and Other Malignancies: A Pilot Study From the Houston VA.
- Autologous haematopoietic cell transplantation for non-Hodgkin Lymphoma with secondary CNS involvement.
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Update on desmoid tumors.
- MicroRNA profiling in cancer.
- RUNX1 regulates corepressor interactions of PU.1.
- Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke.
- MicroRNA profiles of drug-resistant myeloma Cell lines.
- Metastatic malignant melanoma in a patient with Hodgkin's Lymphoma in remission.
- Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell Lymphoma.
- Characterization of a new myeloid Leukemia cell line with normal cytogenetics (CG-SH).
- MicroRNAs regulate critical genes associated with multiple Myeloma pathogenesis.
- The presence or absence of latent Epstein-Barr virus does not alter the sensitivity of Burkitt''s Lymphoma cell lines to proteasome inhibitors.
- Comparative gene expression analysis of a chronic myelogenous Leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine ki...
- Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive Leukemias.
- Graft-versus-host and graft-versus-Leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 20...
- PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's Lymphomas.
- De novo head and neck carcinoma in transplant recipients: preliminary results of management.
- Treatment of Acute myeloid leukemia in a Jehovah''s Witness.
- Primary plasma cell Leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature.
- Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin''s Disease.
- An update on graft-versus-host and graft-versus-Leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22-24, 2004.
- Treatment of advanced Hodgkin''s Disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin''s Lymphoma Study Grou...
- New concepts about graft-versus-host and graft-versus-leukaemia-reactions. A summary of the 5th International Symposium held in Munich, 21 and 22 March 2002.
- Monoclonal gammopathy after low-grade MALT Lymphoma: evidence for a second neoplasm.
- Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's...
- Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignancies.
- Different types of human Leukemias express the message for TNF-alpha and interleukin-10.
- Levels of insulin-like growth factor after stem Cell transplantation.
- Incidence of tumors after treatment with oral anticoagulants.
- Radiochemotherapy in head and neck neoplasms.
- Modulation of CD95 in Leukemia and lymphoma cells by retinoids.
- Second malignancies after Hodgkin''s Disease: the Munich experience.
- Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of proState cancer cells.
- P53-immunoreactive Cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
- Further characterization of cyclophosphamide resistance: expression of CD95 and of bcl-2 in a CML Cell line.
- Vitamin D analogs, Leukemia and WAF1.
- Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
- Methylation of the p16INK4A gene in multiple Myeloma.
- Renal complications in Acute leukemias.
- Phase I study of taxol in refractory Acute myelogenous leukemias using a weekly schedule.
- Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion Lymphoma cells.
- HHV-8 (KSHV) does not establish latency in proState cancer cell lines.
- Soluble CD95 in the serum of patients with low and intermediate grade malignant Lymphomas: absence of prognostic correlations.
- Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killing.
- Serum lipids in patients with Hodgkin''s Disease in complete remission.
- Flt3 ligand stimulates proliferation and inhibits apoptosis of Acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
- Contrast enhancement and quantitative signal analysis in MR imaging of multiple Myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biop...
- Second malignancies.
- A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid Leukemia.
- Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of Acute myelogenous leukemias by TNF-alpha and IFN-gamma.
- Soluble FAS (CD95) is not elevated in the serum of patients with myeloid Leukemias, myeloproliferative and myelodysplastic syndromes.
- Autoantibodies against p53 are not increased in human ascites and pleural effusions.
- Bcl-2 is expressed in human natural killer Cells and is regulated by interleukin-2.
- Soluble CD44 is not elevated in blood products.
- Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's Disease. Verification by laparotomy in 100 cases.
- 54-year-old patient with Anemia, jaundice, hepatosplenomegaly and paravertebral space-occupying lesions.
- Bone marrow involvement in Hodgkin's Disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.
- Second malignancy in patients with Hodgkin Disease in full remission. Interim results.
- Expression of the Fas antigen on primary human Leukemia cells.
- Small Cell prostatic carcinoma. Presentation of diagnosis, therapy and prognosis based on a case report.
- The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes.
- Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant Cells in ascites and pleural effusion.
- Interaction between tumor necrosis factor-alpha and HSP 70 in human Leukemia cells.
- Effects of tumor necrosis-factor on primary human Leukemia cells: ultrastructural changes.
- TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 Cells.
- Graft versus host Disease with fatal outcome after administration of filtered erythrocyte concentrates.
- Lennert''s Lymphoma and glomerulonephritis.
- Serum androgens in intensive-care patients: correlations with clinical findings.
- Tumor necrosis factor: an update on basic research and clinical applications.
- Septic temperatures and throat pain in a patient with hyperthyroidism.
- A Ph1 chromosome positive B Cell line expresses the fusion protein P 210.
- In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic Cells.
- Tumor necrosis factor: receptors on hematopoietic Cells.
- Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer Cell lines.
- Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor.
- Tumor necrosis factor: recent advances.
- In vitro action of tumor necrosis factor on myeloid Leukemia cells.
- Flow cytometry of TPA-induced changes in cells of chronic B-cell Leukemias.
- Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor.
- Vitamin D compounds. Effect on clonal proliferation and differentiation of human Myeloid cells.
- Induction of features characteristic of hairy cell Leukemia in chronic lymphocytic Leukemia and prolymphocytic Leukemia cells.
- Simultaneous demonstration of two antigens on single T Cells using antibodies with contrasting labels.
- In vitro differentiation of human melanoma Cells analyzed with monoclonal antibodies.
- In-vitro induction of some features of hairy cell Leukemia in chronic lymphocytic Leukemia and immunocytoma cells.
- Patients with a deficiency of natural killer Cell activity lack the VEP13-positive lymphocyte subpopulation.
- Killer cell activity of human monoblastic Leukemia cells as detected with a monocyte-specific target cell.
- The use of VEP13 monoclonal antibody for definition of natural killer Cells: spontaneous killer Cells directed against fresh human leukaemia Cells carry the VEP13 anti...
- Lymphocyte markers in sarcoidosis and tuberculosis.
- Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell Lymphomas and pseudoLymphomas.
- Development and properties of a monoclonal antibody specific for human ecto-5''-nucleotidase.
- Immunofluorescence with monoclonal antibodies on poly-L-lysine coated slides: an alternative to conventional methods.
- Analysis with monoclonal antibodies of human lymphoid Cells forming rosettes with rabbit red blood Cells.
- Crossreaction of monoclonal anti-T-cell antibodies: implications for classifying B-cell Leukemias.
- Histiocytic Sarcoma as a Secondary Malignancy: Pathobiology, Diagnosis, and Treatment.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Hospital
-
University Health Shreveport
Drug Facts
| NPI NUMBER | 1578560322 | |
| NPPES Provider LastName | MUNKER | |
| NPPES Provider FirstName | REINHOLD | |
| NPPES Provider ZIPCode | 711034228 | |
| NPPES Provider State | LA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 342.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 7.02 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578560322 |
| Last Name Of The Provider | MUNKER |
| First Name Of The Provider | REINHOLD |
| View All |
Similar Doctors
|
|
Dr. Ben H. Quinney Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Glass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vikas Dembla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali Mansouri, MD |
|
|
Dr. Philip A. Haddad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hazem E. El-Osta, MD |
|
|
Dr. Nebu V. Koshy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael R. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles G. Hargon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anil Veluvolu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin M. Gallagher, MD |
|
|
Dr. Swetha Panati, MD |
|
|
Dr. John P. Ponugupati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn M. Mills, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamran Shahid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhishek H. Patel, MD |
|
|
Dr. Tannaz Armaghany, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Syed H. Jafri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerhard Hildebrant, MD |